Detalhe da pesquisa
1.
Carfilzomib or bortezomib in combination with cyclophosphamide and dexamethasone followed by carfilzomib maintenance for patients with multiple myeloma after one prior therapy: results from a multicenter, phase II, randomized, controlled trial (MUKfive).
Haematologica
; 106(10): 2694-2706, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33910333
2.
Noninvasive ventilation: An important option in the management of hemidiaphragm paralysis.
J Card Surg
; 36(10): 3921-3923, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34260766
3.
Investigating the potential clinical benefit of Selumetinib in resensitising advanced iodine refractory differentiated thyroid cancer to radioiodine therapy (SEL-I-METRY): protocol for a multicentre UK single arm phase II trial.
BMC Cancer
; 19(1): 582, 2019 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31200667
4.
PRISM protocol: a randomised phase II trial of nivolumab in combination with alternatively scheduled ipilimumab in first-line treatment of patients with advanced or metastatic renal cell carcinoma.
BMC Cancer
; 19(1): 1102, 2019 Nov 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31727024
5.
HER2 overexpression and amplification as a potential therapeutic target in colorectal cancer: analysis of 3256 patients enrolled in the QUASAR, FOCUS and PICCOLO colorectal cancer trials.
J Pathol
; 238(4): 562-70, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26690310
6.
Experiences of establishing an academic early phase clinical trials unit.
Clin Trials
; 14(4): 349-356, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28532202
7.
Bendamustine, thalidomide and dexamethasone combination therapy for relapsed/refractory myeloma patients: results of the MUKone randomized dose selection trial.
Br J Haematol
; 170(3): 336-48, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25891006
8.
Extended follow-up and the feasibility of Panobinostat maintenance for patients with Relapsed Multiple Myeloma treated with Bortezomib, Thalidomide, Dexamethasone plus Panobinostat (MUK six open label, multi-centre phase I/II Clinical Trial).
Br J Haematol
; 185(3): 573-578, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30125960
9.
The impact of postoperative complications on long-term quality of life after curative colorectal cancer surgery.
Ann Surg
; 259(5): 916-23, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24374539
10.
Panitumumab and irinotecan versus irinotecan alone for patients with KRAS wild-type, fluorouracil-resistant advanced colorectal cancer (PICCOLO): a prospectively stratified randomised trial.
Lancet Oncol
; 14(8): 749-59, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23725851
11.
The use of master protocols for efficient trial design to evaluate radiotherapy interventions: a systematic review.
J Natl Cancer Inst
; 2024 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38720568
12.
Brain Re-Irradiation Or Chemotherapy: a phase II randomised trial of re-irradiation and chemotherapy in patients with recurrent glioblastoma (BRIOChe) - protocol for a multi-centre open-label randomised trial.
BMJ Open
; 14(3): e078926, 2024 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38458809
13.
The TICOPA protocol (TIght COntrol of Psoriatic Arthritis): a randomised controlled trial to compare intensive management versus standard care in early psoriatic arthritis.
BMC Musculoskelet Disord
; 14: 101, 2013 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-23517506
14.
The Role of Pretherapy Quantitative Imaging and Dosimetry in Radioiodine Therapy for Advanced Thyroid Cancer.
J Nucl Med
; 64(7): 1125-1130, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37116914
15.
Daratumumab, Cyclophosphamide, Bortezomib, Lenalidomide, and Dexamethasone as Induction and Extended Consolidation Improves Outcome in Ultra-High-Risk Multiple Myeloma.
J Clin Oncol
; 41(23): 3945-3955, 2023 08 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37315268
16.
Implementation of the Time-to-Event Continuous Reassessment Method Design in a Phase I Platform Trial Testing Novel Radiotherapy-Drug Combinations-CONCORDE.
JCO Precis Oncol
; 6: e2200133, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36446040
17.
A Road Map for Designing Phase I Clinical Trials of Radiotherapy-Novel Agent Combinations.
Clin Cancer Res
; 28(17): 3639-3651, 2022 09 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35552622
18.
Effect of AZD4017, a Selective 11ß-HSD1 Inhibitor, on Bone Turnover Markers in Postmenopausal Osteopenia.
J Clin Endocrinol Metab
; 107(7): 2026-2035, 2022 06 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35275196
19.
Ixazomib with cyclophosphamide and dexamethasone in relapsed or refractory myeloma: MUKeight phase II randomised controlled trial results.
Blood Cancer J
; 12(4): 52, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35365598
20.
A phase IB and randomised phase IIA trial of CApecitabine plus Radium-223 (Xofigo™) in breast cancer patients with BONe metastases: CARBON trial results.
J Bone Oncol
; 35: 100442, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35800293